New stock first day | Doess-B (02526) first listed, opening at 121.21% in the morning, the company deeply cultivates the track of medical imaging large model platform

De Shi-B (02526) made its debut on the stock exchange. The announcement shows that each share is priced at 99 Hong Kong dollars, with a total of 7.9992 million shares issued and 50 shares per lot, resulting in a net amount of approximately 7.198 billion Hong Kong dollars. As of the time of drafting, it has risen by 121.21%, reaching 219 Hong Kong dollars, with a trading volume of 181 million Hong Kong dollars. Public information shows that De Shi Bio has been focusing on the medical imaging large model platform track, launching the iMedImage medical imaging universal large model in 2025, creating the world's first trillion-level parameter cross-modal medical imaging base model. In simple terms, this model breaks through the limitations of traditional medical imaging AI single modalities, covering 19 medical imaging modalities such as CT, MRI, ultrasound, pathology, chromosomes, and over 90% of clinical medical imaging scenarios, changing the traditional industry development mode from scratch. With a trillion-level parameter scale, this model has become the largest universal medical imaging base model globally. The prospectus shows that the company's revenue in the first nine months of 2025 surged by 469.8% year-on-year to reach 1.12 billion yuan, with a high gross profit margin of 75.9%. The gross profit margin of the technology licensing business even reached 96.5%, becoming the core engine of revenue growth. By September 2025, the company's products had been deployed in over 400 medical institutions nationwide, with a adoption rate of 40% in the top ten hospitals in China (such as Peking Union Medical College Hospital and Fudan University affiliated Zhongshan Hospital).